当前位置:首页 > 股票大全 > 海正药业 600267 财务分析

海正药业财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

海正药业(600267)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入2,726,615,253.710,373,071,956.928,700,895,404.716,060,103,056.03
营业总成本2,578,018,340.8210,134,419,762.128,115,484,387.675,564,001,745.74
营业利润272,881,031.289,442,971.17629,069,077.94550,256,415.27
利润总额270,589,142.98-82,866,731.58580,799,298.28503,502,808.33
净利润246,349,992.85-97,014,961.51472,914,417.84431,107,180.61
其他综合收益-717,310.311,311,827.062,079,722.813,165,501.87
综合收益总额245,632,682.54-95,703,134.45474,994,140.65434,272,682.48
海正药业(600267)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计6,374,058,982.966,358,825,683.346,613,067,438.926,464,347,071.86
非流动资产合计11,056,074,971.2511,254,456,019.3811,534,024,737.5911,869,466,414.39
资产总计17,430,133,954.2117,613,281,702.7218,147,092,176.5118,333,813,486.25
流动负债合计7,209,120,101.076,583,615,124.336,584,008,005.56,736,667,799.43
非流动负债合计1,931,148,913.292,680,252,905.192,709,893,823.42,705,035,967.77
负债合计9,140,269,014.369,263,868,029.529,293,901,828.99,441,703,767.2
归属于母公司股东权益合计8,044,565,413.48,101,974,562.678,585,910,5368,629,051,463.93
股东权益合计8,289,864,939.858,349,413,673.28,853,190,347.618,892,109,719.05
负债和股东权益合计17,430,133,954.2117,613,281,702.7218,147,092,176.5118,333,813,486.25
海正药业(600267)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计2,896,949,513.5711,501,222,253.489,405,878,053.196,410,248,496.61
经营活动现金流出小计2,581,859,593.579,998,552,806.748,084,827,824.45,668,523,409
经营活动产生的现金流量净额315,089,9201,502,669,446.741,321,050,228.79741,725,087.61
投资活动现金流入小计20,375,485.6673,166,764.1590,743,635.2154,146,021.3
投资活动现金流出小计65,313,096.92411,872,836.65431,155,538.02377,932,338.5
投资活动产生的现金流量净额-44,937,611.26-338,706,072.5-340,411,902.81-323,786,317.2
筹资活动现金流入小计2,116,000,0003,856,835,988.042,670,152,438.582,079,152,438.58
筹资活动现金流出小计2,387,799,785.474,861,043,404.183,434,788,519.72,503,105,785.01
筹资活动产生的现金流量净额-271,799,785.47-1,004,207,416.14-764,636,081.12-423,953,346.43
汇率变动对现金及现金等价物的影响892,114.614,717,641.853,419,097.894,839,906.38
现金及现金等价物净增加额-755,362.12164,473,599.95219,421,342.75-1,174,669.64
期末现金及现金等价物余额1,328,867,292.791,329,622,654.911,384,570,397.711,163,974,385.32
海正药业600267相关数据
今日股市大盘指数